Jeffrey B. Mirviss Boston Scientific Corp (BSX) insider trading activity

Jeffrey B. Mirviss is EVP&Pres, Periph Intervent of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 25,766 shares of BSX, which is worth approximately $2.68 Million. The most recent transaction as insider was on Feb 18, 2023, when has been sold 1,002 shares (Common Stock) at a price of $46.54 per share, resulting in proceeds of $46,633. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.8K

0% 3M change

8.05% 12M change

Total Value Held $2.68 Million

Jeffrey B. Mirviss Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2023	SELL Payment of exercise price or tax liability	$46,633 $46.54 p/Share	1,002 Reduced 1.07%	92,607 Common Stock
Feb 18 2023	BUY Exercise of conversion of derivative security	-	2,817 Added 2.92%	93,609 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$47,470 $46.54 p/Share	1,020 Reduced 1.09%	92,853 Common Stock
Feb 17 2023	SELL Open market or private sale	$95,527 $46.35 p/Share	2,061 Reduced 2.22%	90,792 Common Stock
Feb 17 2023	BUY Exercise of conversion of derivative security	-	3,333 Added 3.43%	93,873 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$42,250 $46.48 p/Share	909 Reduced 0.98%	91,949 Common Stock
Feb 16 2023	SELL Open market or private sale	$65,927 $46.79 p/Share	1,409 Reduced 1.53%	90,540 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	2,970 Added 3.1%	92,858 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$29,414 $47.29 p/Share	622 Reduced 0.69%	89,888 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	-	2,031 Added 2.19%	90,510 Common Stock
Jan 04 2023	SELL Open market or private sale	$313,111 $46.38 p/Share	6,751 Reduced 7.09%	88,479 Common Stock
Jan 01 2023	SELL Payment of exercise price or tax liability	$149,452 $46.27 p/Share	3,230 Reduced 3.28%	95,230 Common Stock
Jan 01 2023	BUY Exercise of conversion of derivative security	-	9,981 Added 9.2%	98,460 Common Stock
Dec 12 2022	SELL Open market or private sale	$517,990 $46.75 p/Share	11,080 Reduced 11.13%	88,479 Common Stock
Dec 09 2022	SELL Open market or private sale	$1,893,626 $46.15 p/Share	41,032 Reduced 29.19%	99,559 Common Stock
Dec 09 2022	BUY Exercise of conversion of derivative security	$387,154 $13.08 p/Share	29,599 Added 17.39%	140,591 Common Stock
Dec 03 2022	SELL Payment of exercise price or tax liability	$13,793 $46.6 p/Share	296 Reduced 0.27%	110,992 Common Stock
Dec 03 2022	BUY Exercise of conversion of derivative security	-	649 Added 0.58%	111,288 Common Stock
Nov 01 2022	SELL Bona fide gift	-	230 Reduced 0.21%	110,639 Common Stock
May 16 2022	SELL Bona fide gift	-	26 Reduced 0.02%	110,290 Common Stock
Apr 20 2022	SELL Open market or private sale	$448,492 $46.5 p/Share	9,645 Reduced 8.04%	110,316 Common Stock
Apr 19 2022	SELL Open market or private sale	$500,000 $45.5 p/Share	10,989 Reduced 8.39%	119,961 Common Stock
Mar 22 2022	SELL Open market or private sale	$500,002 $44.5 p/Share	11,236 Reduced 7.9%	130,950 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$27,562 $44.17 p/Share	624 Reduced 0.44%	142,186 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	2,037 Added 1.41%	142,810 Common Stock

JBM

Jeffrey B. Mirviss

EVP&Pres, Periph Intervent

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account